5 Biotech Stocks in Billionaire Ray Dalio's Portfolio
In this piece, we will take a look at the 5 biotech stocks in billionaire Ray Dalio's portfolio. If you want more details about Mr.
Novocure Ltd (NVCR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sciencast Management Qing Li | 4,149 | $278 | +32% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $96.50 | 104 | Officer, Director | 13,276 | 2021-11-26 | Filing | |
| $103.37 | 1,000 | Officer, Director | 13,172 | 2021-11-26 | Filing | |
| $102.36 | 3,870 | Officer, Director | 12,172 | 2021-11-26 | Filing | |
| $85.01 | 4,200 | Officer | 98,786 | 2020-09-02 | Filing | |
| $6.93 | 125,000 | Director | 6,125,000 | 2017-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $74.00 | 5,396 | Officer | 28,672 | 2022-08-03 | Filing | |
| $71.09 | 563 | Officer | 34,068 | 2022-08-03 | Filing | |
| $69.66 | 837 | Officer, Director | 551,176 | 2022-08-02 | Filing | |
| $69.66 | 437 | Officer | 34,631 | 2022-08-02 | Filing | |
| $69.66 | 414 | Officer | 102,193 | 2022-08-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,116,230 | $633,578 | 0.66% | |
| 2. | 407,348 | $28,311 | 0.01% | |
| 3. | 355,214 | $24,687 | 0.28% | |
| 4. | 296,784 | $20,626 | 0.25% | |
| 5. | 266,777 | $18,541 | 0.01% |
News See All
NovoCure Limited (NVCR) Fell Out Of Favor With Hedge Funds
At Insider Monkey, we pore over the filings of nearly 867 top investment firms every quarter, a process we have now completed for the latest reporting period.
Here is What Hedge Funds Think About NovoCure Limited (NVCR)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should I Buy NovoCure Limited (NVCR)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Hedge Fund and Insider Trading News: Man Group, Paulson & Co., Millennium Management, Archegos Capital Management, Novocure Ltd (NVCR), Target Corporation (TGT), and More
The retail investing boom is showing signs of slowing down, and short sellers are seizing on the trend as Reddit “meme-stocks” tank.
Is NVCR A Good Stock To Buy Now According To Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Funds Are Done Buying NovoCure Limited (NVCR)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Did Hedge Funds Make The Right Call On NovoCure Limited (NVCR) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Billionaire Hedge Funds
